Dr. Varun Goel

Professional Journey

AWARD

• Health Icon of the Year – Golden Star Awards 2016 by National Institute for Education Research (NIER).
• Medical excellence award 2020 by national institute for education research (NIER).

DIPLOMATE NATIONAL BOARD THESIS GUIDE

Presently Thesis co-guide for DNB medical oncology students in the department of Medical Oncology Rajiv Gandhi Cancer Institute & Research Center for diplomate national board for Medical Oncology.

• Dr Udeep (2016): Role of capecitabine Maintenance chemotherapy in inoperable and Metastatic Carcinoma Stomach patients.
• Dr. Amrith Patel (2017): Frontline Folfox chemotherapy in metastatic carcinoma stomach patients.

PUBLICATIONS AND RESEARCH WORK

(* as first author)

• Hepatic osteodystrophy. Trop Gastroenterol. 2010; 31:82-6.
• Chemokine receptor 5 (CCR5) polymorphism in chronic hepatitis B patients treated with three different nucleos(side) analogues. Indian J Med Res. 2013; 137:1208-9.
• Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas. International Journal of Trichology 2014; 6:23-24.
• Small cell carcinoma of the ovary of hypercalcemic type: a rare tumor. Natl J Med Res. 2014; 4:113-115.
• Primary renal primitive neuroectodermal tumor: A rare presentation. J Postgrad Med. 2015; 61:126-8.
• Case report: Non-small-cell lung carcinoma presenting as foot swelling. Lung India: Official Organ of Indian Chest Society.
• Two cases of ovarian carcinoma with endobronchial metastases: Rare presentation. South Asian J Cancer 2015; 4:149
• FOLFOX-4 is second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients. Japanese Journal of Clinical Oncology, 2015, 1–6.
• Altretamine in advanced pretreated epithelial ovarian carcinoma patients; experience from a centre in north india. Current Medicine Research and Practice, Volume 6, Issue 3 , 109 – 112.
• Impact of dengue fever on cancer patients: case series. Current Medicine Research and Practice, Volume 6, Issue 4, 157 – 159.
• Gemcitabine and cisplatin in inoperable, loco-regionally advanced and metastatic gallbladder cancer: A study from Northern India cancer institute. Int J Hepatobiliary Pancreat Dis 2016; 6:108–113.
• *Efficacy and toxicity of cetuximab with chemotherapy in recurrent and metastatic head and neck cancer: A prospective observational study. Indian J Cancer 2016; 53:487-92
• *Study of efficacy and safety of modified adjuvant intraperitoneal chemotherapy regimen in carcinoma ovary. Indian J Cancer. 2016 Oct-Dec;53(4):607-611.
• Gemcitabine and Carboplatin in Inoperable, LocoRegionally Advanced and Metastatic Gallbladder Cancer- A Study from Northern Indian Cancer Institute. British Journal of Medicine & Medical Research, 19(12): 1-7, 2017.
• Unusaual tree bark like skin pigmentation over veins after 5-fluorouracil infusion with spontaneous resolution. International journal of science and research methodology, human. 2017 sep;7(3):26-29.
• A Rare Cause of Headache in Common Cancer: Ovarian Carcinoma with Brain Metastasis. Indian J Gynecol Oncolog (2019) 17: 11.
• Methotrexate induced neurotoxicity: A stroke mimic. International Journal of Medical and Health Research, Volume 4; Issue 4; April 2018; Page No. 32-34.
• Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: A study from North India Cancer Centre. Indian J Cancer 2018; 55:222-5.
• Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer. Indian J Med Res 2020; 152:475-81.
• Maheshwari U, Rajappa SK, Talwar V, Goel V, Dash PK, Sharma M, et al. Adjuvant chemotherapy in uterine carcinosarcoma: Comparison of a double and a triplet chemotherapeutic regimen. Indian J Cancer [Epub ahead of print]
• Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: prospective study from cancer center in northern India; Accepted and to be published in South Asian Journal of Oncology.
• *A rare gastric malignancy at gastro jejunostomy stump Cancer Research,Statistics and Treatment Apr–Jun 2020 – Volume 3 – Issue 2 – p 312-316
• Manuscript # IJMS_20_2020 titled” Ecchymoses As a Presenting Sign OF a Solid Malignancy, Accepted for Publication in Indian Journal Of Medical Sciences.
• Dogra A, Talwar V, Goel V, Sekhon R, Rawal SK. First-line chemotherapy analysis on survival in carcinoma ovary patients: Data from a Northern Indian cancer center. J Can Res Ther [Epub ahead of print] [cited 2022 Dec 13]. Available from: https://www.cancerjournal.net/preprintarticle.asp?id=323175
• Efficacy of PARP Inhibitors in the Treatment of Ovarian Cancer: A Literature-Based Review. Asian J Oncol 2019; 5:1–18
• Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India. Int J Mol Immuno Oncol 2019;4(3):63-6
• Pancreatic giant cell tumor: a variant of pancreatic adenocarcinoma with aggressive course. Asian J Oncol 2018; 4:79-80
• Miliary Brain Metastasis—A Rare Pattern of Metastases from Breast Cancer. South Asian J Cancer 2021.
• Isolated splenic recurrence of treated jejunal cancer: A case report with brief review of literature. ijmpo
• Cancer-related fatigue in carcinoma urinary bladder patients receiving chemotherapy: A single institutional study from northern India. Journal of Clinical Oncology 2019 37:7_suppl, 361-361
• Soft Palate Metastasis a Rare Site Of Metastasis In TCC Of Urinary Bladder. Journal of Medical Sciences 2017; 20(1):47-48.
• Basnet B, Goyal P, Mahawar V, Bothra SJ, Agrawal C, Thapa BB, Talwar V, Jain P, Babu Koyyala VP, Goel V, Batra U, Doval DC. Role of 18F-Flurodeoxyglucose Positron-Emission Tomography/Computed Tomography in the Evaluation of Early Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Triple-Negative Breast Cancer. Indian J Nucl Med. 2020 Apr-Jun;35(2):105-109.
• Goyal P, Doval DC, Agarwal C, Jain P, Chaudhari K, Domadia K, Redhu P, Koyyala VPB, Goel V, et al. Current Treatment Approaches for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Adjuvant and Neoadjuvant Settings. Ind J Med Paediatr Oncol 2021; 42:35–45
• Koyyala VP, Sharma M, Goyal P, Goel V, Bommera S, Agrawal M, Domadia K, Choudhary K, Bothra S, Jajodia A, Amrith B P, Joga S, Pasricha S, Batra U. Epidemiological, clinical profile, and treatment outcome of stage iv nonsquamous nonsmall cell lung cancer patients presenting to tertiary care hospital in North India. Oncol J India 2021; 5:104-10.
• Study of efficacy and toxicity profile of gemcitabine and erlotinib based chemotherapy regimen in locally advanced (inoperable) and metastatic carcinoma pancreas. European Journal of Molecular & Clinical Medicine. Volume08, Issue04,2021.
• Domadia K, Goel V, Koyyala VPB, Patnaik N, Chaudhari K, Raina S, et al. Study of Gemcitabine Plus Nab-Paclitaxel-Based Chemotherapy Regimen as First-Line Treatmentin Metastatic Pancreatic Carcinoma. South Asian J Cancer 2022;11(1):31–35.
• Agarwal, H., Talwar, V., Anand, S., Goel, V., & Patnaik, N. (2022). Psychological challenges encountered by health care professionals having a risk of accidental exposure and its impact on their wellbeing in a non-covid hospital during the prevailing pandemic.International Journal of Health Sciences,6(S3), 816–822.
• Joga S, Bansal A, Talwar V, Bothra S, Dash P, Goel V, et al. Spontaneous pulmonary arterial embolization: A rare complication of the silicon- based peripherally inserted central venous catheter(PICC). The Journal of Vascular Access. 2022;23(3): 471–3.
• Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, Soni S, Jain A. Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy. World J Clin Oncol. 2022 May 24;13(5):339-351.
• Jajodia, A., Goel, V., Goyal, J., Patnaik, N., Khoda, J., Pasricha, S., Gairola, M. Combined Diagnostic Accuracy of Diffusion and Perfusion MR Imaging to Differentiate Radiation-Induced Necrosis from Recurrence in Glioblastoma. Diagnostics 2022, 12, 718
• Jajodia A, Goel V, Patnaik N, Pasricha S, Gupta G, Batra U, Talwar V. Analysis of Spatial Heterogeneity of Responses in Metastatic Sites in Renal Cell Carcinoma Patients Treated with Nivolumab. Tomography. 2022; 8(3):1363-1373.
• Raffaella Casolino, Chiara Braconi et al. the BABEL working group of the COST Action 18122 (EURO-CHOLANGIO-NET), part of the European Network for the Study of CholangiocarcinomaBridging the equity gap in patient education: the biliary tract cancer BABEL project. Lancet; Volume 23, ISSUE 5, P568-570, May 01, 2022.
• Maheshwari U, Sharma M, Goel V, Goyal P, Jain P, Agarwal C, et al. Clinical Profile and Outcomes of Treatment in Gastric Cancer in Young Patients in India. Asian J Oncol 2022; 8:111–118.
• Patnaik N, Pasricha S, Gupta G, Durga G, Sharma SK, Sharma A, Kamboj M, Goel V, Jajodia A, Mehta A. EBV positive diffuse large B-cell lymphoma, NOS in a patient of Crohn’s disease treated with immunomodulator. Indian J Pathol Microbiol 2022; 65:739-41
• Goyal P, Jain P, Agrawal C, Bothra S, Talwar V, Batra U, Goyal S, Maheshwari U, Chaudhari K, Goel V, BP A, Doval DC et al. Breast Cancer in Transgenders: Narrative Review. Ind J Med Paediatr Onco. Article published online: 2022-07-28.
• Narayan S, Talwar V, Redhu P, Goel V, Jain A, Soni S, et al. Serpentine Supra-venous Hyperpigmentation “Badge of Courage” in Fight Against Cancer: An Brief Review. Gulf J Oncolog. 2022 Sep;1(40) 83-7.

PUBLICATION / ABSTRACTS

• Goel V, Kar P. Hepatic osteodystrophy. Trop Gastroenterol. 2010;31(2):82- 86.
• Goel V, Bose PD, Sarma MP, Hazam RK, Das BC, Gondal R, Kar P. Chemokine receptor 5 (CCR5) polymorphism in chronic hepatitis B patients treated with three different nucleos(t)ide analogues. Indian J Med Res. 2013;137( 6):1208-1209.
• Goel V, Raina S, Chandragouda D, Singh S, Talwar V, Patnaik N. Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas. Int J Trichology. 2014;6(1):23-24.
• Dodagoudar C, Mahanta A, Goswami V, Goel V, Doval DC, Talwar V, Batra U, Singh S, Chauhan D. Efficacy and toxicity of FOLFOX-4 as a second-line chemotherapy in locally advanced unresectable and metastatic carcinoma gall bladder: a prospective observational study. American Society of Clinical Oncology; 2014.
• Upadhyay A, Goel V, Batra U, Goyal P, Dutta K, Aggarwal M, Doval DC. Two cases of ovarian carcinoma with endobronchial metastases: rare presentation. South Asian J Cancer. 2015;4(3):149.
• Goel V, Dgouda C, Singh S, Raina S, Talwar V, Patnaik N, Pasricha S. Small cell carcinoma of the ovary of hypercalcemic type: a rare tumor. Goel V, Talwar V, Dodagoudar C, Singh S, Sharma A, Patnaik N. Primary renal primitive neuroectodermal tumor: a rare presentation. J Postgrad Med. 2015; 61(2):126-128.
• Singh S, Mishra A, Goel V, Talwar V, Raina S, Dodagaudar C, Mitra S, Saxena U, Shekhon R, Rawal S. Neo-adjuvant chemotherapy followed by surgery vs definitive chemo radiation as treatment for localized carcinoma cervix. European J Cancer. 2015;51:S539-S540.
• John MC, Goel V, Tiwari S, Talwar V, Patnaik N. Case report: non-small-cell lung carcinoma presenting as a foot swelling. Lung India. 2015;32(3):292-293.
• Singh S, Mishra A, Goel V, Talwar V, Raina S, Dodagaudar C, Mitra S, Saxena U, Shekhon R, Rawal S. 2727 Neo-adjuvant chemotherapy followed by surgery vs definitive chemo radiation as treatment for localized carcinoma cervix. Eur J Cancer. 2015;51:S539-S540.
• Tiwari S, Goel V, John MC, Patnaik N, Doval DC. Efficacy and toxicity of cetuximab with chemotherapy in recurrent and metastatic head and neck cancer: A prospective observational study. Indian J Cancer. 2016;53(4):487-492.
• Goel V, Dash P, Talwar V, Singh S, Doval DC, Patnaik N. Efficacy and safety of adjuvant intraperitoneal chemotherapy in carcinoma ovary: a prospective observational study. American Society of Clinical Oncology; 2016.
• Manana SS, Goel V, Talwar V, Raina S. NAB-paclitaxel as third-line therapy after failure of gemcitabine and 5-FU based combinations in advanced gall bladder cancer patients. Ann Oncol. 2016;27:vi236.
• Dodagoudar C, Doval DC, Mahanta A, Goel V, Upadhyay A, Goyal P, Talwar V, Singh S, John MC, Tiwari S, et al. FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients. Jpn J Clin Oncol. 2016;46(1):57-62.
• Goel V, Singh S, Talwar V, Goyal P, Upadhyay A, et al. Study of efficacy and safety of adjuvant intraperitoneal chemotherapy in carcinoma ovary. Asian J Oncol. 2016;2(S01):056.
• Dash P, Goel V, Talwar V, Doval DC, Raina S, Goyal P, Upadhyay A, Patnaik
• Study of efficacy and safety of modified adjuvant intraperitoneal chemotherapy regimen in carcinoma ovary. Indian J Cancer. 2016;53(4):607-611.
• Goel V, Talwar V, Singh S, Doval DC, Patnaik N. Study of efficacy and toxicity profile of gemcitabine and erlotinib based chemotherapy regimen in locally advanced (inoperable) and metastatic carcinoma pancreas. Pancreatology. 2016; 16(1):S9.
• Goel V, Talwar V, Patnaik N, Raina S, Singh S. 241P NAB-paclitaxel as third- line therapy after failure of gemcitabine and 5-fluorouracil (5-FU) based combinations in advanced gallbladder cancer patients. Ann Oncol. 2016;27:ix75- ix76.
• Talwar V, Goel V, Raina S, Talwar J, Patnaik N, Doval DC. Dengue fever in cancer patients: retrospective analysis. Curr Med Res Pract. 2016;6(4):157-159.
• Talwar V, Goel V, Raina S, Patnaik N, Doval DC. Altretamine in advanced pretreated epithelial ovarian carcinoma patients: experience from a center in north India. Curr Med Res Pract. 2016;6(3):109-112.
• Talwar V, Rajpurohit S, Goel V, Raina S, Chandragauda D. Gemcitabine and carboplatin combination chemotherapy in treatment naive patients with inoperable gall bladder cancer. Eur J Cancer. 2016;54:S9.
• Singh S, Goel V, Talwar V, Raina S, Mitra S, Saxena U, Shekhon R, Rawal S. Neo-adjuvant chemotherapy followed by surgery versus definitive chemo radiation as treatment for localized carcinoma cervix. Asian J Oncol. 2016;2(S01):022.
• Talwar V, Raina S, Goel V, Doval DC. Gemcitabine and cisplatin in inoperable, loco-regionally advanced and metastatic gallbladder cancer: a study from Northern India cancer institute. Int J Hepatobiliary Pancreat Dis. 2016;6:108- 113.
• Prashant V, Singh S, Talwar V, Goyal P, Upadhyay A. Ovary: oral abstract. Asian J Oncol. 2016;2:1.
• Talwar V, Raina S, Goel V, Doval DC. Gemcitabine and carboplatin in inoperable, loco-regionally advanced and metastatic gallbladder cancer—A study from Northern Indian Cancer Institute. Br J Med Med Res. 2017;19(12):1-7.
• Raina S, Goel V, Talwaar V, et al. Soft palate metastasis: a rare site of metastasis in TCC of urinary bladder. JMS SKIMS. 2017;20(1):47-48.
• Goel V, Jain A, Tiwari S, John MC, Talwar V, Dash P, et al. Randomised prospective study of maintenance tamoxifen versus post adjuvant chemotherapy surveillance only in advanced ovarian cancer patients. Ann Oncol. 2017;28:v339.
• Venkata PPB, Talwar V, Goel V, Prasantha K, Bajaj R, Sharma M, Medisetty P, Ram D, Agrawal C, et al. Unusual tree bark-like skin pigmentation over veins after 5-fluorouracil infusion with spontaneous resolution. Human Journals. 2017;7 (3).
• Jajodia A, Koyyala VPB, Goel V, Dash PK, Rajappa SK, Amrith BP. Pancreatic giant cell tumor: a variant of pancreatic adenocarcinoma with aggressive course. Asian J Oncol. 2018;4:79-80.
• Goel V, Tiwari S, Talwar V, Pattnaik N, Dash P, Raina S, John MC. 56P plasma circulating ctDNA: potential biomarker in non-small cell lung carcinoma and clinical significance. J Thorac Oncol. 2018;13(4):S29.
• Venkata PPB, Talwar V, Raina S, Goel V, Dash PK, Bajaj R, Sharma M, Medisetty P, Ram D, Agrawal C, et al. Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: a study from North India Cancer Centre. Indian J Cancer. 2018;55(3):222-225.
• Talwar V, Bothra SJ, Goel V, Dash PK, Jajodia A, Domadia K, Choudhary K, Koyyala VPB. Real world outcomes of checkpoint inhibitors immunotherapy in renal and urothelial cancers in a tertiary care cancer center in India. Int J Mol Immuno Oncol. 2019;4(3):63-66.
• Talwar V, Goel V, Dash P. Cancer-related fatigue in carcinoma urinary bladder patients receiving chemotherapy: a single institutional study from northern India. American Society of Clinical Oncology; 2019.
• Dash PK, Koyyala VPB, Suryavanshi M, Jajodia A, Pasricha S, Goel V, Bothra SJ, Goyal S, Batra U, Doval DC. Adoption of molecular testing in breast cancer in a tertiary care center in a developing country. Ann Oncol. 2019;30:ix127.
• Goswami V, Koyyala VPB, Goyal S, Sharma M, Goel V, Dhamne N, Maheshwari U, Sharma A. Efficacy of PARP inhibitors in the treatment of ovarian cancer: a literature-based review. Asian J Oncol. 2019;5(1):1-18.
• Agrawal CR, Sharma M, Talwar V, Goel V, Singh AP. Isolated splenic recurrence of treated jejunal cancer: a case report with brief review of literature. Indian J Med Paediatr Oncol. 2019;40(S01):S163-S165.
• Amrith BP, Koyyala VPB, Dash PK, Goel V, Bansal D, Talwar V. A rare cause of headache in common cancer: ovarian carcinoma with brain metastasis. Indian J Gynecol Oncol. 2019;17:1-4.
• Talwar V, Raina S, Goel V, Dash P, Doval DC. Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer. Indian J Med Res. 2020;152(5):475-481.
• Chaudhari KA, Talwar V, Goel V, Dash PK, Bothra S, Domadia K, Koyyala VPB. A rare malignancy at the gastrojejunostomy stump. Cancer Res Stat Treat. 2020;3(2):312-316.
• Goyal P, Maheshwari U, Jain P, Agrawal C, Chaudhari KA, Goyal S, Batra U, Bothra S, Goel V, Talwar V, et al. Rectal cancer in young patients: clinicoepidemiologic profile and treatment outcomes. American Society of Clinical Oncology; 2020.
• Koyyala VPB, Jajodia A, Beer L, Doval DC, Talwar V, Goel V, Batra U, Goyal S, Gupta A, Chaturvedi A, et al. 215P analysis of spatial heterogeneity of responses in metastatic sites with nivolumab in renal cell carcinoma. Ann Oncol. 2020;31:S1324.
• Basnet B, Goyal P, Mahawar V, Bothra SJ, Agrawal C, Thapa BB, Talwar V, Jain P, Koyyala VPB, Goel V, et al. Role of 18F-flurodeoxyglucose positron- emission tomography/computed tomography in the evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer. Indian J Nucl Med. 2020;35(2):105-109.
• Koyyala VPB, Goyal S, Jajodia A, Goel V, Amrith BP, Soni S, Doval DC. Miliary brain metastasis—a rare pattern of metastases from breast cancer. South Asian J Cancer. 2020;9(03):188-189.
• Sharma M, Talwar V, Maheshwari U, Koyyala VPB, Goel V, Goyal S, Dash PK, Batra U, Bajaj R, Yadav A, et al. Role of maintenance gemcitabine in advanced carcinoma gallbladder. South Asian J Cancer. 2020;9(04):204-208.
• Maheshwari U, Rajappa SK, Talwar V, Goel V, Dash PK, Sharma M, et al. Adjuvant chemotherapy in uterine carcinosarcoma: comparison of a doublet and a triplet chemotherapeutic regimen. Indian J Cancer. 2021;58(2):179-184.
• Goyal P, Doval DC, Agarwal C, Jain P, Chaudhari K, Domadia K, Redhu P, Koyyala VPB, Goel V, Batra U, et al. Current treatment approaches for human epidermal growth factor receptor 2-positive breast cancer in adjuvant and neoadjuvant settings. Indian J Med Paediatr Oncol. 2021;42(01):35-45.
• Goel V, Jain P, Goyal P, Patnaik N, Pasricha S, Koyyala V, Talwar V. P-48 Study of paclitaxel and ramucirumab as second-line therapy after failure of FOLFOX-6 regimen in metastatic stomach carcinoma patients. Ann Oncol. 2021; 32:S112.
• Goel V, Patnaik N, Talwar V, Chaudhari K, Koyyala V, Goyal P. P-194 Study of efficacy and safety of combination of octreotide acetate LAR with lenvatinib as second-line therapy in patients with advanced G1-G2 NETs of non-pancreatic origin. Ann Oncol. 2021;32:S166.
• Goel V, Patnaik N, Koyyala VPB, Talwar V, Chowdhary K, Jain P, Goyal P, Raina S. 1447P efficacy and toxicity profile of trans dermal buprenorphine for cancer pain management: experience from a tertiary care center in northern India. Ann Oncol. 2021;32:S1078.
• Talwar V, Patnaik N, Goyal P, Doval DC, Goel V. Study of efficacy and toxicity profile of gemcitabine and erlotinib based chemotherapy regimen in locally advanced (inoperable) and metastatic carcinoma pancreas. Eur J Mol Clin Med. 2021;8(4):949-958.
• Koyyala VPB, Kulkarni PS, Goel V, Goteti SC, Purohit SR, Jajodia A, et al. 67P Challenges to molecular testing for selecting targeted therapies for oncology patients in India. Ann Oncol. 2021;32:S1366.
• Koyyala VPB, Sharma M, Goyal P, Goel V, Bommera S, Agrawal M, et al. Epidemiological, clinical profile, and treatment outcome of stage IV nonsquamous nonsmall cell lung cancer patients presenting to tertiary care hospital in North India. Oncol J India. 2021;5(3):104-110.
• Koyyala VPB, Chandra S, Goel V, Pasricha S, Gupta M, Muppalla BS, et al. 76P Need for awareness about immune-related adverse events (iRAEs) among community physicians in India. Ann Oncol. 2021;32:S1405.
• Joga S, Bansal A, Talwar V, Bothra SJ, Dash P, Goel V, Koyyala VPB. Spontaneous pulmonary arterial embolization: a rare complication of the silicon- based peripherally inserted central venous catheter (PICC). J Vasc Access. 2022; 23(3):471-473.
• Dogra A, Talwar V, Goel V, Sekhon R, Rawal S. First-line chemotherapy analysis on survival in carcinoma ovary patients: data from a Northern Indian cancer center. J Cancer Res Ther. 2022;18(6):1589-1596.
• Domadia K, Goel V, Koyyala VPB, Patnaik N, Chaudhari K, Raina S, Doval DC, Talwar V. Study of gemcitabine plus nab-paclitaxel-based chemotherapy regimen as first-line treatment in metastatic pancreatic carcinoma. South Asian J Cancer. 2022;11(01):031-035.
• Jajodia A, Goel V, Goyal J, Patnaik N, Khoda J, Pasricha S, Gairola M. Combined diagnostic accuracy of diffusion and perfusion MR imaging to differentiate radiation-induced necrosis from recurrence in glioblastoma. Diagnostics. 2022;12(3):718.
• Agarwal H, Talwar V, Anand S, Goel V, Patnaik N. Psychological challenges encountered by health care professionals having a risk of accidental exposure and its impact on their wellbeing in a non-Covid hospital during the prevailing pandemic. Int J Health Sci. 2022;5(S3):816-822.
• Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, et al. Co- relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy. World J Clin Oncol. 2022; 13(5):339-351.
• Maheshwari U, Sharma M, Goel V, Goyal P, Jain P, Agarwal C, et al. Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian J Oncol. 2022;8(03):111-118.
• Casolino R, Braconi C, Prete MG, Romero FG, Castro RE, Banales JM, et al. Bridging the equity gap in patient education: the biliary tract cancer BABEL project. Lancet Oncol. 2022;23(5):568-570.
• Jajodia A, Goel V, Patnaik N, Pasricha S, Gupta G, Batra U, Talwar V. Analysis of spatial heterogeneity of responses in metastatic sites in renal cell carcinoma patients treated with nivolumab. Tomography. 2022;8:1363-1373.
• Patnaik N, Pasricha S, Gupta G, Durga G, Sharma SK, Sharma A, et al. EBV positive diffuse large B-cell lymphoma, NOS in a patient of Crohn’s disease treated with immunomodulator. Indian J Pathol Microbiol. 2022;65(3):739-741.
• Narayan S, Talwar V, Redhu P, Goel V, Jain A, Soni S, et al. Serpentine supra-venous hyperpigmentation “Badge of Courage” in fight against cancer: a brief review. Gulf J Oncol. 2022;1(40):83-87.
• Amrith BP, Goel V, Joga S, Koyyala VPB, Goyal S, Batra U, Doval DC, Talwar V. 122P Efficacy and safety of mFOLFOX-6 in advanced gastric cancer: a prospective observational study. Ann Oncol. 2022;33:S1480.
• Jajodia A, Goel V, Goyal J, Patnaik N, Khoda J, Pasricha S, Gairola M. Combined diagnostic accuracy of diffusion and perfusion MR imaging to differentiate radiation-induced necrosis from recurrence in glioblastoma. Diagnostics. 2022;12:718.
• Aggarwal A, Goel S, Sayed AI, Goel V, Talwar V, Singh S. Interaortocaval lymph node metastasis in gall bladder cancer: is it regional node or metastatic disease? J Gastrointest Cancer. 2023;54(4):1252-1260.
• Maheshwari U, Goyal P, Goel V, Patnaik N, Koyyala VPB, Chaudhari K, et al. Study of efficacy and toxicity of capecitabine maintenance after response to docetaxel, cisplatin, and 5-fluracil-based chemotherapy in advanced carcinoma stomach. Gulf J Oncol. 2023;42(42):40-46.
• Goyal P, Joga S, Tripathi R, Jain A, Sharma M, Goel V, et al. Real world experience with osteosarcoma from a tertiary cancer centre in India. J Cancer Sci Clin Ther. 2023;7(2):93-99.
• Chaudhari V, Ramaswamy A, Srinivas S, Agarwal A, Seshadri RA, Talwar V, et al. Practice patterns and survival in patients with resected pancreatic ductal adenocarcinomas (PDAC)—results from the multicentre Indian pancreatic & periampullary adenocarcinoma project (MIPPAP) study. J Gastrointest Cancer. 2023;54(4):1338-1346.
• Mitra S, Simson DK, Gehani M, Barik S, Khurana R, Singh S, et al. Survival and recurrence patterns in patients with stomach adenocarcinoma receiving chemotherapy or chemoradiotherapy after D2 gastrectomy in a tertiary care cancer institute: a retrospective real-world evidence cohort study. Adv Radiat Oncol. 2023;8(6):101280.
• Soni S, Jain A, Goyal V, Narayan S, Redhu P, Goyal P, Swamy S, Talwar V. Modified FOLFIRINOX as the first-line chemotherapy in unresectable and metastatic pancreatic adenocarcinoma—a single-center experience in India. Ann Pancreatic Cancer. 2023;6:9.
• Goyal V, Jain A, Basu D, Soni S, Talwar V. Unveiling the uncommon: disseminated intravascular coagulation as an unusual presentation of metastatic carcinoma prostate. IP Arch Cytol Histopathol Res. 2023;8(2):119-122.
• Goyal P, Jain P, Agrawal C, Jain SB, Talwar V, Batra U, et al. Breast cancer in transgenders: narrative review. Indian J Med Paediatr Oncol. 2024;45(01):003- 008.
• Saha S, Goel V, Chakraborty A, Talwar V. Synchronous triple malignancy of esophagus, pancreas, and pyriform sinus: a prima facie report. Indian J Surg Oncol. 2024;15(Suppl 2):349-354.
• Jain A, Goyal V, Soni S, Narayan S, Redhu P, Shivarudraiah SS, Talwar V. Hair depigmentation in a patient treated with pazopanib: a case report and a comprehensive analysis. Indian J Skin Allergy. 2024;1-3.
• Goyal P, Mukherjee A, Tripathi R, Doval DC, Talwar V, Goyal S, et al. Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer from India. American Society of Clinical Oncology; 2024.
• Goyal P, Doval DC, Jain S, Talwar V, Goyal S, Batra U, et al. Survival and safety analysis of eribulin in Indian patients with metastatic breast cancer: a real world clinical experience. American Society of Clinical Oncology; 2024.
• Jain A, Soni S, Goyal V, Narayan S, Redhu P, Basu DA, et al. Cardiac metastases: an unusual site for colon cancer metastases. Int J Clin Stud Med Case Rep. 2024;41(4):002.
• Gupta M, Singh S, Talwar V, Goyal S, Batra U, Goel S, et al. 430P Is Ga68- FAPI PET-CT a new imaging standard in poorly cohesive carcinoma stomach? An initial experience in comparison to FDG PET-CT. Ann Oncol. 2024;35:S174.
• Jain A, Goyal V, Soni S, Narayan S, Redhu P, Shivarudraiah SS, et al. 261P Evaluating tumor regression grade in locally advanced rectal cancer: identifying predictive factors and clinical implications following neoadjuvant chemoradiotherapy. Ann Oncol. 2024;35:S111.
• Jain A, Soni S, Domadia KR, Goyal V, Goyal P, Narayan S, et al. 345P Match-pair analysis of mFOLFIRINOX vs gemcitabine+ nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: survival and toxicity outcomes. Ann Oncol. 2024;35:S143-S144.
• Jain A, Goel V, Soni S, Narayan S, Redhu P, Basu DA, et al. Targeted precision: antibody-drug conjugates revolutionize urothelial carcinoma therapy. Curr Trends Intern Med. 2024;8(233):1-5.
• Ramaswamy A, Chaudhari V, Srinivas S, Bhargava P, Kannan S, Agarwal A, et al. Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients—a match-pair analysis from a multi-institutional cohort study (The MIPPAP study). HPB. 2024.
• Gupta M, Singh S, Talwar V, Goyal S, Batra U, Goel S, et al. Diagnostic performance of Ga68-FAPI in signet ring cell carcinoma stomach in comparison to FDG: an initial experience. Society of Nuclear Medicine; 2024.
• Patel AB, Goel V, Joga S, Koyyala VPB, Goyal S, Doval DC, et al. Efficacy and safety of mFOLFOX-6 in advanced gastric cancer: a prospective observational study. South Asian J Cancer. 2024.
• Mahajan S, Simson DK, Antony V, Pahuja A, Pansuriya M, Goel S, et al. 100P Treatment outcomes in rectal cancer with radiological positive circumferential resection margin treated with short course radiation therapy. Ann Oncol. 2024;35:S1441.
• Patnaik N, Duggal R, Dua A, Singh J, Mane PS, Saxena S, Goel V. 434P: clinicopathological characteristics and aggressive behavior of SMARCA4-deficient undifferentiated thoracic tumors mimicking NSCLC: data from a tertiary cancer center in India. J Thorac Oncol. 2025;20(3):S251.
• Chowdhury S, Aggarwal A, Goel S, Goel V, Talwar V, Singh S. Gastric cancer with limited peritoneal metastasis: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Indian J Gastroenterol. 2025;1-8.

ONGOING RESEARCH STUDIES IN THE INSTITUTE:

• To estimate the prevalence of BRCA1 and BRCA2 gene mutation positivity in patients of high grade serous epithelial carcinoma of Ovary of North India attending tertiary care hospital in Delhi
• To assess adjuvant chemotherapy related toxicity profile and survival in ovarian cancer patients from center in northern India
• A pilot study to assess BRCA-1 positivity among patients of Pancreatic duct adenocarcinoma attending tertiary care centre in North India
• A Prospective, Multicentre, Phase-IV Clinical Trial of Olaparib in Indian Patients with Platinum Sensitive Relapsed Ovarian Cancer who are in Complete or Partial Response Following Platinum Based Chemotherapy and Metastatic Breast Cancer with Germline BRCA1/2 Mutation (SOLI Study).
• A Phase III Randomized, Double-Blind, Placebo-Controlled, Multi-Regional, International Study of Durvalumab in Combination with Gemcitabine plus Cisplatin versus Placebo in Combination with Gemcitabine plus Cisplatin for Patients with First-Line Advanced Biliary Tract Cancers (TOPAZ-1).
• A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India (CheckMate 7C9)
• A Multicountry, Multicentre, Noninterventional, Retrospective Study to Describe the Real-world Management Outcomes in Patients With Unresectable Hepatocellular Carcinoma
• A Phase 2, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Trastuzumab Deruxtecan (T-DXd, DS-8201a) for the Treatment of Selected HER2 Expressing Tumors (DESTINY‐PanTumor02)
• EMERALD-3: A Phase III, Randomized, Open-Label, Sponsor-Blinded, Multicenter Study of Durvalumab in Combination With Tremelimumab ± Lenvatinib Given Concurrently With TACE Compared to TACE Alone in Patients With Locoregional Hepatocellular Carcinoma
• An open-label randomized trial of the efficacy and safety of Zanidatamab with standard-of-care therapy against standard-of-care therapy alone for advanced HER2-positive biliary tract cancer. (JZP598-302)
• A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator’s Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 (CLARITY- Gastric 01 Study)
• A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination with Chemotherapy as Adjuvant Treatment after Resection of Biliary Tract Cancer with Curative Intent (ARTEMIDE-Biliary01)
• A Prospective, Multicenter, Observational Registry of Metastatic ColoRectal cancer (mCRC) Disease to determine Demographics, Molecular features, Clinical features and Treatment outcomes in patients undergoing treatment at participating centers
• Real-World Treatment Patterns and Clinical Outcomes Among Patients with Urothelial Carcinoma (UC) in India
• Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Adenocarcinoma of the Prostate
• An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

POSTER PRESENTATIONS:

• Efficacy & safety profile of gemcitabine & erlotinib combination in advanced Ca Pancreas in India. UAE CANCER CONGRESS 2016.
• NAB-PACLITAXEL -as third-line therapy after failure of gemcitabine and 5-FU based combinations in advanced gall bladder cancer patients. ESMO ASIA 2016
• Efficacy and toxicity of cetuximab with chemotherapy in recurrent and metastatic head and neck cancer: A prospective observational study. ASHNO 2017
• Soft palate metastasis – a rare site of metastasis in TCC of urinary bladder. 30th ICON Ahmadabad.
• Transdermal buprenorphine for cancer pain management: experience from a tertiary care centre in northern india. 2018 the Japanese Society of Medical Oncology Annual Meeting.
• Plasma circulating ctDNA: Potential biomarker in non-small cell lung carcinoma and clinical significance. European Lung Cancer Congress (ELCC) 2018.
• Randomised prospective study of maintenance tamoxifen versus post adjuvant chemotherapy surveillance only in advanced ovarian cancer patients. ESMO (European Society for Medical Oncology) 2017.

ORAL PRESENTATIONS:

• Febrile neutropenia: management – Elite Criticlave 2018″ at Prague, Czech Republic.
• Role of immunological drugs as second line therapy in H&N cancer patients – ASHNO 2019, Seoul, Korea.
• Study of Efficacy and Toxicity of Capecitabine Maintenance After Response to Docetaxel, Cisplatin, and 5-Fluracil-Based Chemotherapy in Advanced Carcinoma Stomach.
• 3rd International Conference on Cancer and Breast Cancer Therapy 2025 Dubai, UAE

BOOK CHAPTER:

• CML- Recent Advances in management
• The API Medicine update Vol: XIV 2014.
• Management of Metastatic Breast Cancer
• The API medicine update Vol 25; 2015; pg 750-754.
• Endometrial cancer in textbooks of oncology. 2019
• Hepato – Biliary Cancers. API Textbook 11th Edition; 2019.
• Hepato – Biliary Cancers. API Textbook 12th Edition; 2021.
• Ovarian cancer. Textbook on clinical oncology. 2020.

ORGANIZING SEMINARS/ WORKSHOPS/CONFERENCE :

• Co-organizing secretary PANCREATIC CANCER conference 2018, the theme New Horizons.
• Co-organizing secretary IMMUNO ONCOLOGY SUMMIT 9th Nov 2019 At Delhi

CERTIFICATION GCP TRAINING

• Minimum Criteria for ICH E6 GCP Investigator Site Personnel Training, 2.0, Completed on 20.02.2020